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Abstract
Background: Multiple rib fractures are common injuries in both the young and elderly. Rib fractures account for
10% of all trauma admissions and are seen in up to 39% of patients after thoracic trauma. With morbidity and
mortality rates increasing with the number of rib fractures as well as poor quality of life at long-term follow-up,
multiple rib fractures pose a serious health hazard. Operative fixation of flail chest is beneficial over nonoperative
treatment regarding, among others, pneumonia and both intensive care unit (ICU) and hospital length of stay. With
no high-quality evidence on the effects of multiple simple rib fracture treatment, the optimal treatment modality
remains unknown. This study sets out to investigate outcome of operative fixation versus nonoperative treatment
of multiple simple rib fractures.
Methods: The proposed study is a multicenter randomized controlled trial. Patients will be eligible if they have
three or more multiple simple rib fractures of which at least one is dislocated over one shaft width or with
unbearable pain (visual analog scale (VAS) or numeric rating scale (NRS) > 6). Patients in the intervention group will
be treated with open reduction and internal fixation. Pre- and postoperative care equals treatment in the control
group. The control group will receive nonoperative treatment, consisting of pain management, bronchodilator
inhalers, oxygen support or mechanical ventilation if needed, and pulmonary physical therapy. The primary
outcome measure will be occurrence of pneumonia within 30 days after trauma. Secondary outcome measures are
the need and duration of mechanical ventilation, thoracic pain and analgesics use, (recovery of) pulmonary
function, hospital and ICU length of stay, thoracic injury-related and surgery-related complications and mortality,
secondary interventions, quality of life, and cost-effectiveness comprising health care consumption and productivity
loss. Follow-up visits will be standardized and daily during hospital admission, at 14 days and 1, 3, 6, and 12 months.
Discussion: With favorable results in flail chest patients, operative treatment may also be beneficial in patients with
multiple simple rib fractures. The FixCon trial will be the first study to compare clinical, functional, and economic
outcome between operative fixation and nonoperative treatment for multiple simple rib fractures.
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Background
Rib fractures are common injuries in both trauma and
non-trauma centers, occurring in up to 10–39% of pa-
tients with blunt chest trauma and accounting for 10%
of all trauma admissions [1–4]. With an estimated 25%
of all traumatic deaths, chest trauma ranks second after
head injury [3, 4]. Rib fractures are caused by high-en-
ergy trauma (HET) in the younger patients, often with
concomitant injuries, and in the elderly as a result of
low energy trauma (LET) [5–7]. Sustaining multiple rib
fractures can result in a flail chest, defined as fracture of
three or more consecutive ribs in two or more places,
creating a flail segment [8, 9]. Patients may also have
multiple simple rib fractures or a combination of both.
While open surgical fixation of rib fractures dates back
to the 1940s, multiple rib fractures are routinely treated
nonoperatively [10]. Nonoperative treatment includes pain
management, oxygen support or mechanical ventilation,
bronchodilator inhalers, and pulmonary physical therapy.
Despite this treatment strategy, mortality and complica-
tions such as pulmonary contusion, hemopneumothorax,
and pneumonia are seen in up to 34% and in 35–77% of
patients, respectively [1, 2, 5, 6, 11–15]. Various studies
have identified risk factors that increase mortality such as
age and number of rib fractures [3, 6, 7, 11, 16–18].
Furthermore, at 2 years post-injury, up to 29% of pa-
tients have not yet returned full time to their pre-injury
job and 64% of patients with isolated multiple rib fractures
still experience chest wall pain [19, 20]. With incapacitat-
ing pain often accompanying traumatic rib fractures, epi-
dural analgesics are suggested as the optimal analgesic for
patients with multiple rib fractures. Two meta-analyses
have shown that epidural use results in significant less
pain but has no benefit regarding the length of both inten-
sive care unit (ICU) and hospital stay, mortality, and com-
plication rate, indicating the necessity of an optimized
analgesic modality for rib fracture patients [21, 22].
Rib fractures may show the same pattern as a restrictive
pulmonary disease, resulting in loss of total lung capacity
which precipitates inadequate oxygenation and ventilation.
Patients with rib fractures and reduced pulmonary func-
tion are more susceptible to pulmonary complications and
longer length of hospital stay [23–25]. With contradicting
studies on the difference in spirometry between opera-
tively and nonoperatively treated patients with rib frac-
tures, additional research is needed [12–14, 26–29]. While
surgical treatment of flail chest patients appears to be
cost-effective over nonoperative treatment, but for mul-
tiple simple rib fractures, the most cost-effective treatment
modality is still unknown [30, 31].
Over the last decade, there has been an increasing
number of studies suggesting superior results of open
reduction and fixation (ORIF) for the stabilization of
multiple rib fractures due to profitable results in trau-
matic flail chests compared with nonoperative manage-
ment [31–34]. Several studies with flail and non-flail
chest patients combined have shown promising effects
of ORIF with less pneumonia, less hemo- and pneumo-
thorax, shorter need for mechanical ventilation, lower
mortality, shorter length of hospital and ICU stay, and
quicker return to normal activity [15, 28, 35–38].
As only two studies, both retrospective cohort studies
with small sample sizes and short follow-up, have singu-
larly focused on operative versus nonoperative manage-
ment of multiple simple rib fractures, definitive proof
for the optimal treatment of multiple simple rib frac-
tures is not achieved yet [9, 14, 39–41].
Therefore, the aim of this multicenter randomized
controlled trial is to investigate the effect of ORIF versus
nonoperative treatment in patients who sustained mul-
tiple simple fractured ribs.
Methods/design
Objective
The primary aim of this trial is to investigate the effect
of ORIF versus nonoperative treatment on the occur-
rence of pneumonia within 30 days after trauma in adult
patients who sustained multiple simple fractured ribs.
The secondary aims are to investigate the effect of treat-
ment on the need for and duration of mechanical venti-
lation, level of thoracic pain and analgesics use,
(recovery of ) pulmonary function, hospital and ICU
length of stay, thoracic injury-related and surgery-related
complications and mortality, secondary interventions,
quality of life, and total costs (in-hospital and socio-eco-
nomic) of treatment, health care consumption, and work
absence. At the end, a cost-effectiveness analysis will be
done.
Trial design and setting
The FixCon trial is a multicenter randomized controlled
trial, with a parallel group design. The following 12 hos-
pitals in The Netherlands will participate: Amphia Zie-
kenhuis (Breda), Catharina Ziekenhuis (Eindhoven),
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Deventer Ziekenhuis (Deventer), Erasmus MC (Rotter-
dam), Haga Ziekenhuis (The Hague), Ikazia Ziekenhuis
(Rotterdam), Isala (Zwolle), Maasstad Ziekenhuis (Rot-
terdam), Maastricht UMC+ (Maastricht), Rijnstate (Arn-
hem), Spaarne Gasthuis (Haarlem), and Zuyderland
Medisch Centrum (Heerlen).
Inclusion and exclusion criteria
The study population will consist of adults with three or
more simple rib fractures after blunt force trauma. The
fracture pattern will be diagnosed and delineated with a
CT scan of the thorax, at least 64-slice and preferable in-
cluding 3D reconstruction.
In order to be eligible to participate in this study, a pa-
tient must meet all of the following inclusion criteria:
1. Age 18 years or older
2. For any of the ribs number 4 to 10, three simple
fracture ribs with either A) at least one fracture
dislocated over one shaft-width; or B) unbearable
pain (VAS or Numeric Rating Scale (NRS) >6
points)
3. Blunt force trauma
4. Hospital presentation within 72 h after trauma
5. Provision of informed consent by patient or proxy
A patient who meets any of the following criteria will
be excluded from participation:
1. Neurotraumatic changes leading to mechanical
ventilation (GCS ≤ 8 at 48 h post-injury. If unable to
assess full GCS due to intubation or other causes,
GCS motor ≤ 4 at 48 h post-injury)
2. Rib fractures due to cardiopulmonary resuscitation
3. Surgical rib fixation not possible due to additional
traumatic injuries (hemodynamically or pulmonary
unstable, for example, based on parenchymal lung
trauma) or the patient is unfit for surgery, to be
decided by an ICU doctor, trauma surgeon, or
anesthesiologist
4. Flail chest, based on radiological or clinical findings
5. Decreased sensory or motor function due to
(previous) cervical or thoracic spine failure
6. Previous rib fractures or pulmonary problems,
requiring continuous oxygen use at home pre-
trauma
7. Congenital thoracic deformity (pectus excavatum,
pectus carinatum, severe scoliosis, or kyphosis)
8. Inhalation trauma or severe burns close to or inside
the mouth or neck
9. Surgical fixation of the ribs not feasible within
7 days after trauma
10. Patient unwilling or unable to comply with the
intervention or follow-up visit schedule
11. Insufficient comprehension of the Dutch language
to understand the rehabilitation program and other
treatment information in the judgement of the
attending physician
12. Participation in another surgical intervention or
drug study that might influence any of the outcome
parameters
Recruitment and randomization
Eligible persons presenting to the emergency department
(ED) or referred from another hospital, with multiple, sim-
ple rib fractures will be informed about the trial at the ED
or at the surgical ward after admission. After explanation
of the study, eligible patients will receive written informa-
tion and a consent form from the attending physician, the
clinical investigator, or a research assistant. Patients meet-
ing all eligibility criteria will be recruited within 1 day after
hospital admission. As surgical rib fixation appears to be
most beneficial when performed within 72 h after trauma,
patients are stimulated to decide within this period. How-
ever, informed consent can be given by the patient as long
as rib fixation can be carried out within 1 week after
trauma. Should patients not be able to sign informed con-
sent themselves, a legal representative will receive oral
and written information about the study, in the hospital,
by the attending physician, the clinical investigator, or a
research assistant, and will be asked to consent with par-
ticipation of the patient.
After signing informed consent by patient or proxy,
participants are allocated to one of the two study arms
(surgical stabilization or nonoperative treatment) using a
web-based randomization program that will be available
24 h a day. Allocation will be at random and concealed,
in a 1:1 ratio, and will be stratified by site. Variable block
sizes will be used; in each block, both treatments will be
represented equally. As the intervention cannot be
blinded, it will in no case be necessary to break the
randomization code.
As with many surgical trials, patients and surgeons
cannot be blinded for the intervention. In order to re-
duce bias as much as possible, a research physician or
research assistant will perform the follow-up measure-
ments using a standardized protocol. Also, the treating
surgeon or ICU doctor will identify the primary outcome
(i.e., pneumonia) based on the definition as mentioned
under outcome measures.
Participation is on a voluntary basis and participants
are allowed to withdraw from the study at any time
without specifying why. The general practitioner will be
informed about the patients’ participation.
Nonoperative allocation
Nonoperative treatment will consist of optimal pain
treatment, supportive oxygen or ventilation if needed,
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early mobilization, Salbutamol/Atrovent spray, and
physical therapy for optimizing ventilation. Without de-
finitive proof for the best protocol, each participating
center is allowed to use its local protocol for interpleural
drainage use, mechanical ventilation, and pain control.
Although this may introduce some heterogeneity across
hospitals, it benefits extrapolation of the results. Critical
elements of the nonoperative treatment will be recorded.
Operative allocation
Preoperative treatment is the same as in the nonopera-
tive treatment group. ORIF should be preferably carried
out within 72 h after trauma, but fixation within 1 week
will not lead to exclusion. The surgical fixation will be
conducted by a senior fracture management surgeon
who has participated in at least five rib fracture fixation
procedures. A surgeon in training with limited experi-
ence in rib fixation is allowed to work under supervision
of an experienced surgeon.
Patients allocated to the surgical group will undergo
ORIF using plates and/or splints. The decision on what rib
fixation system to use is to the discretion of the treating
surgeon, provided that the fixation system is CE-mark ap-
proved for rib fixation. Each system will be used according
to the supplier’s protocol. The patient will receive an intra-
venous single prophylactic dose of a third-generation ceph-
alosporin preoperatively. The incision will be planned,
based preferably on a preoperative 3D reconstruction of the
thoracic cage. The positioning of the patient and number of
ribs fixated will be left to the preference of the operating
surgeon. A minimally invasive technique will not lead to
exclusion of the study. The ribs will be visualized using a
muscle-sparing approach. After removing interpositioning
tissue, fracture reduction will be carried out and the rib fix-
ation device will be positioned and fixated. The use of inter-
pleural space rinsing with warmed NaCl 0.9% or
thoracoscopic visualization during rib fixation will be left to
the judgement of the surgeon. If indicated, an interpleural
drain is percutaneously placed in dorsocaudal direction,
apart from the surgical wound. The wound is closed, using
a wound drain if needed.
After surgery, the patient will be admitted to the ward
or ICU depending on his/her clinical state. Participating
hospitals are allowed to use their local protocol for inter-
pleural and wound drainage. Postoperative physical ther-
apy and supportive treatment may be prolonged if
needed. Postoperative care and preoperative treatment
are the same as for nonoperative management. Critical
elements of the operative treatment will be recorded.
Outcome measures
Primary outcome measure
The primary outcome measure is pneumonia within 30
days after trauma. In order to define pneumonia, the
flowchart of the Centers of Disease Control and Preven-
tion, based on imaging and clinical and laboratory cri-
teria, will be followed (Fig. 1) [42]. Temperature (T) will
be measured daily during admission. If T > 38.0 °C intra-
auricular (or T > 39 °C rectal), bladder, central, or a spu-
tum culture will be done. Also, the wound will be
checked (if applicable) and a radiograph of the thorax
will be made. If patients are suffering from fever at
home, they will be advised to visit the outpatient clinic
or emergency department. The temperature will be mea-
sured on arrival at the outpatient clinic or emergency
department, and the same additional examinations will
be performed. A monitor will independently review the
patient’s medical files in order to ensure that the pneu-
monia was actually present.
Secondary outcome measures
The secondary outcome measures are:
1. Need and duration of mechanical ventilation in
days. The number of days of invasive mechanical
ventilation (by endotracheal tube or tracheostomy)
from intubation until successful weaning will be
determined. The need for mechanical ventilation
will be evaluated based on arterial blood gas
analysis and clinical performance of the patient.
The duration of mechanical ventilation will be
calculated from the dates of intubation and
extubation. Re-intubation within 30 days will be
recorded as well.
2. Level of thoracic pain (NRS) and analgesics use.
Thoracic pain will be determined using an 11-point
Numeric Rating Scale (NRS) in which 0 implicates
no pain and 10 the worst possible pain. Five
thoracic pain levels will be analyzed: pain in rest, at
night, during daily activities (e.g., work or hobbies),
during maximal inspiration, and during self-care.
Analgesics use during admission will be extracted
from the medical files. After discharge, analgesics
use will be asked for during the follow-up visits.
Daily narcotic requirement will be calculated using
an equivalence scale for 30 mg/day oral morphine.
3. (Recovery of ) pulmonary function. The parameters
tidal volume (TV), forced vital capacity (FVC),
inspiratory capacity (IClung), and forced expiratory
volume at 1 second (FEV1) will be determined using
spirometry. Spirometry will be done by a member
of the research team. During the spirometry, the
patient has to inhale actively and exhale with
maximum force possible. The mean of three tests
will be calculated.
4. Hospital length of stay expressed in days. This will
be calculated as the time between admission and
discharge from the hospital. Re-admission within
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Fig. 1 Pneumonia flow diagram, as designed by the CDC [42]. For further details of the flow chart, see the website of the CDC [42]
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30 days will be added. Re-admission for thoracic
reasons after 30 days and up to 12 months will be
counted separately.
5. ICU length of stay expressed in days. This will be
calculated similarly to the hospital length of stay.
6. Thoracic injury-related complications and
mortality. The occurrence of thoracic injury-related
complications will be recorded from the medical
charts during clinical admission and each follow-up
visit. Complications will be categorized for level of
severity and treatment necessity according to the
Clavien-Dindo classification [43]. Complications
will include empyema (as diagnosed on CT scan, in
presence of fever or positive cultures in the drained
fluid), (retained) hydrothorax (a heterogeneous fluid
collection with Hounsfield unit readings of 35–70
and evidence of pleural thickening) [44], nonunion
(diagnosed on CT scan or operatively, at least
6 months after trauma) [45], and other (all other
complications as judged by the treating physician).
If mortality is caused by the thoracic injury or
complication of thoracic injury, it will be counted
in rates of mortality. Death caused by other reasons
will be noted but excluded in this calculation.
7. Surgery-related complications. The ORIF group can
also develop hardware-related complications or
failure. Hardware-related complication is superficial
and deep wound infection which is defined as
redness, tenderness, and warmth surrounding and
in direct contact with the postoperative wound.
Superficial infection leads to oral or IV antibiotics,
and deep infection leads to surgical activity such as
stitch removal of exploration of the wound.
Hardware failure is defined as loosening of the
plate, secondary dislocation of fixation material,
malposition of hardware, and broken plates or
splints.
8. Secondary interventions to resolve complications.
Secondary interventions within 12 months after
trauma to relieve pain, treat infection, or other rib
fracture-related problems will include the following:
antibiotic therapy (both oral and intravenous),
additional surgical interventions (e.g., surgical
stabilization of nonunion, evacuation of hematoma,
evacuation of empyema, removal of failed hardware,
symptomatic hardware removal, and treatment of
infection), and additional percutaneous
interventions (e.g., for persistent bleeding
intercostal artery, intraparenchymal bleeding,
drainage of infection, and drainage of pleural fluid).
9. Health-related quality of life measured using the
Short Form-12 (SF-12) and EuroQoL-5D (EQ-
5D) questionnaires. The SF-12 analyzes global
health status, functional scale, and symptom
scale. The score will be calculated based on
eight domains and summarized into a Physical
Component Summary (PCS) and Mental
Component Summary (MCS). Data will be
reported as utility score, ranging from 0 to 1
with a higher value indicating better quality of
life. As a reference, the US population of 1998
will be used [46]. The EQ-5D is the most
commonly used quality of life instrument for
(rib) fracture patients [47, 48]. The EQ-5D is
recommended for assessment of quality of life in
trauma patients, especially for economic
evaluation [49, 50]. The EQ-5D-5 L descriptive
system consists of five dimensions of health
(mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression), each with
five possible answers. The patients’ health states
will be converted into a utility score using the
Dutch tariff [51]. Utility scores range from 0 to 1
with lower scores indicating poorer quality of
life.
10. Cost-effectiveness and health care consumption.
Economic evaluations will be done from a societal
perspective. The validated Medical Consumption
Questionnaire (iMCQ) and Production
Consumption Questionnaire (iPCQ) will be used.
iMCQ details medical specialist care, physical
therapy, hospitalization, nursing home, home care,
and other costs directly associated with diagnosis,
treatment, and rehabilitation. iPCQ comprises work
resumption and production losses. Health care
costs and lost productivity until 1 year after trauma
will be measured in accordance with economic
guidelines [52].
Other data collected
In addition to the outcome measures, the following data
will be collected in order to assess similarity between the
treatment groups:
Intrinsic variables (baseline characteristics): age,
gender, body mass index (BMI), American Society of
Anesthesiologists (ASA) grade, tobacco consumption,
comorbidities, and medication use.
Injury-related variables: injury mechanism, pleura
drain placed, number and location of rib fractures, af-
fected side, presence of sternum fracture, additional in-
juries represented by the Abbreviated Injury Score (AIS)
[53], and Injury Severity Score (ISS).
Intervention-related variables: surgical approach, num-
ber of plates and splints used and for which ribs, surgical
delay, primary and secondary surgeon (resident or staff
surgeon), wound drain, intra-operatively placed inter-
pleural drain including duration of drainage, and dur-
ation of surgery.
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Study procedures
Patients will be followed until 12 months after trauma.
Clinical evaluation will occur daily during hospital ad-
mission. After discharge, outpatient clinic evaluation will
occur at 2 weeks (window 7–21 days), 1 month (window
21–39 days), 3 months (window 11–15 weeks), 6 months
(window 24–28 weeks), and 12 months (window 12–14
months). These visits are standard of care for the tar-
geted patient group. A schedule of events is shown in
Table 1. Baseline data and perioperative data will be col-
lected from the patients’ medical files as soon as pos-
sible, but no later than the first outpatient department
visit. At the 12-month follow-up contact, the surgeon or
research assistant will document any secondary inter-
vention that may be planned for the patient.
After 6 months, a thoracic CT scan is repeated. Pul-
monary function will be tested during the outpatient
clinic visits at 1, 3, 6, and 12months. At each follow-up
visit, the coordinating researcher or research assistant
will ascertain patient status (i.e., adverse events/compli-
cations or secondary interventions) and will verify infor-
mation within the medical records. At each visit,
patients will be asked to complete questionnaires relat-
ing to their pain (NRS), analgesics use, quality of life
(QoL) (SF-12 and EQ-5D), and health care use (iPCQ
and iMCQ).
Sample size calculation
Calculation of the required sample size for the primary
analysis is based on data from a Cochrane review and a
large retrospective analysis [7, 32]. These studies suggest
a pneumonia rate of 35% in nonoperatively treated pa-
tients and 15% in operatively treated patients with mul-
tiple rib fractures. This difference is considered clinically
relevant. A two-sided test with an α level of 0.05 and a β
level of 0.2 requires 72 patients in each group. In order
to account for 25% loss of patients to follow-up and
mortality, a sample size of 90 patients per group is
needed. In total, 180 patients will be included and
randomized.
Statistical analyses
Data will be analyzed using the Statistical Package for
the Social Sciences (SPSS), version 24.0 or higher (SPSS,
Table 1 Schedule of events (duration after trauma)
Radiographs and
event forms
Screening Enrolment Pre-
surgery
Surgery Post-surgery
(until day 7*)
2 weeks
(7–21
days)
30 days
(21–39
days)
3 months
(11–15
weeks)
6 months
(24–28
weeks)
12 months$
(12–14
months)
CT-scan X X
Screening X
Informed consent X
Randomization X
Baseline data X X
Intervention/
surgical report form
X X
Outpatient clinic FU X X X X X
Spirometry X X X X
Analgesic use Daily,
afternoon
Daily,
afternoon
X X X X X
Pain (NRS-rest and
inspiration)
Daily,
afternoon
Daily,
afternoon
X** X X X X
Pain (NRS-night,
daily, and care)
X** X X X X
QoL (EQ-5D and
SF-12)
X** X X X X
Complications X X X X X X X X
(Secondary)
interventions
X X X X X X X
iPCQ and iMCQ
questionnaire
X*** X X X X
Early withdrawal **** **** **** **** ****
*Post-surgery
$May be planned at the patients’ residency
**Asking for current and pre-trauma status
***Asking for pre-trauma situation
****Only if applicable.
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Chicago, IL, USA), and reported following the Consoli-
dated Standards of Reporting Trials (CONSORT) guide-
lines. Normality of continuous data will be tested with
the Shapiro-Wilk test. Homogeneity of variances will be
tested using Levene’s test. The analysis will be performed
on an intention to treat basis. A two-sided p value < 0.05
will be taken as threshold of statistical significance in all
statistical tests. Procedures will be implemented to re-
duce missing data. In previous studies of the principal
investigator’s department, these procedures led to < 5%
missing data [54]. If necessary, missing values will be re-
placed using multiple imputation following the predict-
ive mean matching method, using ten imputations.
Descriptive analysis will be performed in order to re-
port the outcome measures for both treatment arms. For
categorical data, numbers and frequencies will be re-
ported. For continuous data, the mean and SD (paramet-
ric data) or the mean and percentiles (non-parametric
data) will be reported.
Next, univariate analysis will be performed in order to
test for statistical significance of differences between the
primary and secondary outcome measures across the
two groups. A chi-squared analysis or Fisher’s exact test
will be used for statistical testing of categorical data (e.g.,
the primary outcome, pneumonia). Continuous data (i.e.,
hospital length of stay) will be tested using Student’s t
test (parametric data; with equal variance or unequal
variance whichever applies according to Levene’s test) or
Mann-Whitney U test (non-parametric data).
Multivariable analysis will be done as secondary ana-
lysis. A logistic regression model will be developed, with
pneumonia as dependent variable and treatment as co-
variate. Nonoperative treatment will serve as reference
category. Baseline and injury-related variables that may
potentially confound the association between treatment
and outcome will be included in this model as covariate.
These will be selected from literature and from data of
this study (see Other data collected). Known potential
confounders according to literature data are the number
of rib fractures and age. Other potential confounders
collected as part of this study are gender, ASA, COPD,
osteoporosis, and additional injuries (ISS ≥ 16 versus
ISS < 16, and presence versus absence of severe injuries
(AIS ≥ 3) for any body region). Variables that produce a
p value < 0.2 in the univariate analysis will be included
in the regression model. Odds ratios will be reported
with their 95% confidence interval and p value.
Continuous outcomes repeatedly measured over time
will be compared between treatment groups using linear
mixed-effects regression models (with fixed effects for
treatment and other covariates like gender and age, if
applicable). The interaction between treatment and time
will be included to test for differences between groups
over time. For each follow-up moment, the estimated
marginal mean will be computed per treatment group
and compared post hoc with a Bonferroni test in order
to correct for multiple testing.
Other continuous and binomial variables will be tested
with multivariable linear and binary logistic regression
models, respectively. The outcome measure will be en-
tered as dependent variable and treatment as covariate.
Nonoperative treatment will serve as the reference
group. Baseline and injury-related variables that may po-
tentially confound the association between treatment
and outcome will be included in the models as covariate.
Coefficients will be reported with their 95% confidence
interval and p value.
Economic evaluation will be done from a societal per-
spective with iMCQ and iPCQ questionnaires. Health
care costs and lost productivity until 1 year after trauma
will be measured. Cost prices of the standardized referral
strategy will be determined by a bottom-up micro-cost-
ing method. The incremental cost-effectiveness ratio of
ORIF versus nonoperative treatment will be expressed as
costs per pneumonia prevented, with confidence ellipses
and acceptability curves. A cost-utility analysis, with
QALY (based on the EQ-5D summary score) as outcome
measure, will also be done.
Ethical concerns
The study will be conducted according to the principles
of the Declaration of Helsinki (64th World Medical As-
sociation General Assembly, Fortaleza, Brazil, October
2013) and in accordance with the Medical Research In-
volving Human Subjects Act (WMO). This study has
been approved by the Medical Research Ethics Commit-
tee (MREC), in Dutch: Medisch Ethische Toetsings
Commissie (METC). The MREC Erasmus MC has given
dispensation from the statutory obligation to provide in-
surance for subjects participating in medical research
(article 7 of the WMO and Medical Research (Human
Subjects) Compulsory Insurance Decree of 23 June
2003) as participation involves no risks.
Participants can leave the study at any time for any
reason if they wish to do so without having to give a rea-
son. No replacement will take place. Anticipated loss to
follow-up is included in the sample size calculation. Rea-
sons for non-participation will be documented.
Data management and monitoring
Data will be encoded and stored in a password-protected
database (Data Management, The Research Manager,
Deventer, The Netherlands) with restricted access to the
researchers only. Data will be entered once. Quality of
the entered data will be monitored by checking entry for
a random sample of patients prior to database locking.
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Trial status
The trial is registered at the Netherlands Trial Register
(NTR) (NTR7248), registration date May 31, 2018. In-
clusion of patients has started January 1, 2019, and the
planned recruitment period will be 3 years. With a fol-
low-up of 1 year, data presentation is expected in the be-
ginning of 2022.
Discussion
The FixCon trial studies outcome after operative versus
nonoperative treatment of multiple simple rib fractures.
With high rates of morbidity and low quality of life at
long-term follow-up, multiple simple rib fractures cause
a serious health hazard. With favorable results in flail
chest patients, operative treatment might also result in
better clinical and functional recovery of patients with
multiple simple rib fractures. Improved outcome could
translate into less pulmonary complications, shorter hos-
pital stay, less pain, improved quality of life, and quicker
return to normal activities or work compared with non-
operative treatment. Operative treatment, while initially
yielding higher economic costs, could then result in less
financial needs, due to less health care use and less
productivity loss. As a result, primarily performing sur-
gery could be both improving patient outcome and be-
ing the most cost-effective treatment modality.
To the best of our knowledge, this is the first multi-
center randomized controlled trial to evaluate outcome
from patient, medical, and economic perspectives in pa-
tients suffering from multiple simple rib fractures.
Twelve hospitals in the Netherlands will participate in
this trial.
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